We employed two widely-used models of FSGS, the murine 5/6 nephrectomy remnant model and Adriamycin-induced nephropathy model, to test the hypothesis that blocking CCR2 would both reduce proteinuria and improve renal function. This evidence concerns the gene CCR2 and focal segmental glomerulosclerosis.